Urology · Hammond, LA
NPI
1053378166
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
15770 Paul Vega MD Dr
Hammond, LA, 70403
Phone (985) 542-1226
Groups this clinician bills Medicare through
Medicare paid, 2024
$435K
196,094 services
Medicare patients, 2024
389
Average age 74
Drug cost, 2024
$829K
3,615 prescriptions
Company payments, 2025
$1,717
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert B Kidd was code J3145 (injection, testosterone undecanoate, 1 mg), 162,851 times for 53 patients. In total Robert B Kidd billed 196,094 services in 72 codes, and Medicare paid $435K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3145 Injection, testosterone undecanoate, 1 mg | Office | 162,851 | 53 | $1.50 | $244K |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 28,791 | 23 | $0.02 | $536 |
| 99214 Office E&M - Established | Office | 881 | 343 | $91.22 | $80K |
| 81001 Clinical Chemistry | Office | 816 | 342 | $3.09 | $2,525 |
| 96372 Injection Administration | Office | 414 | 75 | $10.64 | $4,407 |
| 82570 Clinical Chemistry | Office | 278 | 211 | $5.06 | $1,407 |
| 82044 Clinical Chemistry | Office | 277 | 211 | $6.09 | $1,686 |
| 51798 Ultrasound - Nonspecific | Office | 167 | 97 | $7.91 | $1,322 |
| 87210 General Laboratory | Office | 94 | 63 | $5.64 | $530 |
| 99215 Office E&M - Established | Office | 72 | 58 | $129.86 | $9,350 |
| 51741 Test - Miscellaneous | Office | 48 | 39 | $7.19 | $345 |
| 99213 Office E&M - Established | Office | 44 | 41 | $67.55 | $2,972 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 36 | $10.59 | $413 |
| 36415 Venipuncture Blood Collection | Office | 36 | 34 | $2.94 | $106 |
| 81007 Clinical Chemistry | Office | 33 | 23 | $29.38 | $970 |
By year: 2022 $367K for 228,463 services; 2023 $364K for 201,203 services; 2024 $435K for 196,094 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 816 | 342 | $3.09 | $2,525 |
| 82570 Clinical Chemistry | 278 | 211 | $5.06 | $1,407 |
| 82044 Clinical Chemistry | 277 | 211 | $6.09 | $1,686 |
| 87210 General Laboratory | 94 | 63 | $5.64 | $530 |
| 36415 Venipuncture Blood Collection | 36 | 34 | $2.94 | $106 |
| 81007 Clinical Chemistry | 33 | 23 | $29.38 | $970 |
| 83986 Clinical Chemistry | 16 | 13 | $3.51 | $56.16 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert B Kidd prescribed most often to Medicare patients was Dutasteride, with 603 prescriptions and refills. In total Robert B Kidd wrote 3,615 Medicare prescriptions that cost $829K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dutasteride Generic | 603 | 1,061 | 139 | $11K |
| Tamsulosin Hcl Generic | 594 | 1,198 | 151 | $5,421 |
| Testosterone Cypionate Generic | 280 | 673 | 99 | $13K |
| Myrbetriq Mirabegron | 137 | 167 | 28 | $71K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 112 | 239 | 23 | $1,879 |
| Gemtesa Vibegron | 111 | 142 | 22 | $66K |
| Estradiol Generic | 107 | 278 | 56 | $9,386 |
| Anastrozole Generic | 104 | 172 | 23 | $367 |
| Silodosin Generic | 93 | 155 | 32 | $5,751 |
| Pentoxifylline Generic | 81 | 119 | 21 | $1,529 |
| Ciprofloxacin Hcl Generic | 80 | 84 | 54 | $622 |
| Doxazosin Mesylate Generic | 78 | 177 | 20 | $400 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 73 | 75 | 59 | $842 |
| Desmopressin Acetate Generic | 52 | 75 | Under 11 | $2,265 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 48 | 56 | 36 | $376 |
Brand drugs: 450 claims; generic drugs: 3,148 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert B Kidd $1,717 ($1,717 in general payments such as food, travel and fees) from 21 companies. The largest payer was Sumitomo Pharma America, Inc. with $262.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 11 | $262 |
| Antares Pharma, Inc. | 10 | $232 |
| Janssen Biotech, Inc. JNJ | 9 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $159 |
| Abbvie Inc. ABBV | 12 | $153 |
| Astellas Pharma US Inc 4503.T | 5 | $129 |
| Pfizer Inc. PFE | 4 | $88.78 |
| Urogen Pharma, Inc. URGN | 2 | $75.15 |
| Dendreon Pharmaceuticals LLC | 4 | $74.47 |
| Teleflex LLC TFX | 1 | $48.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.